Nicardipine prevents cognitive impairment due to chronic hypertension

M. H. Skinner, D. X. Tan

Research output: Contribution to journalArticle

Abstract

Chronic hypertension (HTN) may adversely impact cognitive function in the elderly. Because these effects require years to become measurable, they are difficult to demonstrate in human populations. We used the spontaneously hypertensive rat (SHR) to study the long-term effects of HTN on cognitive performance. Seven SHR and 7 normotensive (WKY) received nicardipine (N) 200 mg/L via drinking water until they reached 20 months of age. A similar number of control (C) SHR and WKY received plain tap water. Cognitive performance was assessed by the Morris water maze, a test of spatial navigation. We found a significant age-associated deterioration in performance of the SHR-C rats (p=.002) but not of the SHR-N, the WKY-N, or the WKY-C (all p>.2). At 20-months of age, performance of the SHR-N was significantly better than the SHR-C (p=.013). There was no difference between WKY-N and WKY-C performance (p>.2). The results suggest that long-standing, untreated HTN leads to impaired cognitive performance, and that nicardipine may provide a protective effect. This animal model may be useful in examining the cognitive effects of chronic HTN and antihypertensive drugs in humans.

Original languageEnglish (US)
Pages (from-to)208
Number of pages1
JournalClinical Pharmacology and Therapeutics
Volume61
Issue number2
StatePublished - 1997

Fingerprint

Nicardipine
Inbred SHR Rats
Hypertension
Water
Cognitive Dysfunction
Drinking Water
Cognition
Antihypertensive Agents
Animal Models
Population

ASJC Scopus subject areas

  • Pharmacology

Cite this

Nicardipine prevents cognitive impairment due to chronic hypertension. / Skinner, M. H.; Tan, D. X.

In: Clinical Pharmacology and Therapeutics, Vol. 61, No. 2, 1997, p. 208.

Research output: Contribution to journalArticle

@article{9270d42c4f184e45b46c45e35c1632ba,
title = "Nicardipine prevents cognitive impairment due to chronic hypertension",
abstract = "Chronic hypertension (HTN) may adversely impact cognitive function in the elderly. Because these effects require years to become measurable, they are difficult to demonstrate in human populations. We used the spontaneously hypertensive rat (SHR) to study the long-term effects of HTN on cognitive performance. Seven SHR and 7 normotensive (WKY) received nicardipine (N) 200 mg/L via drinking water until they reached 20 months of age. A similar number of control (C) SHR and WKY received plain tap water. Cognitive performance was assessed by the Morris water maze, a test of spatial navigation. We found a significant age-associated deterioration in performance of the SHR-C rats (p=.002) but not of the SHR-N, the WKY-N, or the WKY-C (all p>.2). At 20-months of age, performance of the SHR-N was significantly better than the SHR-C (p=.013). There was no difference between WKY-N and WKY-C performance (p>.2). The results suggest that long-standing, untreated HTN leads to impaired cognitive performance, and that nicardipine may provide a protective effect. This animal model may be useful in examining the cognitive effects of chronic HTN and antihypertensive drugs in humans.",
author = "Skinner, {M. H.} and Tan, {D. X.}",
year = "1997",
language = "English (US)",
volume = "61",
pages = "208",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Nicardipine prevents cognitive impairment due to chronic hypertension

AU - Skinner, M. H.

AU - Tan, D. X.

PY - 1997

Y1 - 1997

N2 - Chronic hypertension (HTN) may adversely impact cognitive function in the elderly. Because these effects require years to become measurable, they are difficult to demonstrate in human populations. We used the spontaneously hypertensive rat (SHR) to study the long-term effects of HTN on cognitive performance. Seven SHR and 7 normotensive (WKY) received nicardipine (N) 200 mg/L via drinking water until they reached 20 months of age. A similar number of control (C) SHR and WKY received plain tap water. Cognitive performance was assessed by the Morris water maze, a test of spatial navigation. We found a significant age-associated deterioration in performance of the SHR-C rats (p=.002) but not of the SHR-N, the WKY-N, or the WKY-C (all p>.2). At 20-months of age, performance of the SHR-N was significantly better than the SHR-C (p=.013). There was no difference between WKY-N and WKY-C performance (p>.2). The results suggest that long-standing, untreated HTN leads to impaired cognitive performance, and that nicardipine may provide a protective effect. This animal model may be useful in examining the cognitive effects of chronic HTN and antihypertensive drugs in humans.

AB - Chronic hypertension (HTN) may adversely impact cognitive function in the elderly. Because these effects require years to become measurable, they are difficult to demonstrate in human populations. We used the spontaneously hypertensive rat (SHR) to study the long-term effects of HTN on cognitive performance. Seven SHR and 7 normotensive (WKY) received nicardipine (N) 200 mg/L via drinking water until they reached 20 months of age. A similar number of control (C) SHR and WKY received plain tap water. Cognitive performance was assessed by the Morris water maze, a test of spatial navigation. We found a significant age-associated deterioration in performance of the SHR-C rats (p=.002) but not of the SHR-N, the WKY-N, or the WKY-C (all p>.2). At 20-months of age, performance of the SHR-N was significantly better than the SHR-C (p=.013). There was no difference between WKY-N and WKY-C performance (p>.2). The results suggest that long-standing, untreated HTN leads to impaired cognitive performance, and that nicardipine may provide a protective effect. This animal model may be useful in examining the cognitive effects of chronic HTN and antihypertensive drugs in humans.

UR - http://www.scopus.com/inward/record.url?scp=33748973044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748973044&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748973044

VL - 61

SP - 208

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -